255 related articles for article (PubMed ID: 24742497)
1. Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review.
Mergenhagen K; Ott M; Heckman K; Rubin LM; Kellick K
Clin Ther; 2014 May; 36(5):770-7. PubMed ID: 24742497
[TBL] [Abstract][Full Text] [Related]
2. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
Karimi S; Hough A; Beckey C; Parra D
J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676
[TBL] [Abstract][Full Text] [Related]
3. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
4. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.
Golightly LK; Barber GR; Barron MA; Page RL
Drug Metabol Drug Interact; 2013; 28(1):49-58. PubMed ID: 23314530
[TBL] [Abstract][Full Text] [Related]
5. Does simvastatin cause more myotoxicity compared with other statins?
Backes JM; Howard PA; Ruisinger JF; Moriarty PM
Ann Pharmacother; 2009 Dec; 43(12):2012-20. PubMed ID: 19920157
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
Glueck CJ; Abuchaibe C; Wang P
Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
[TBL] [Abstract][Full Text] [Related]
7. The relationship of vitamin D deficiency to statin myopathy.
Gupta A; Thompson PD
Atherosclerosis; 2011 Mar; 215(1):23-9. PubMed ID: 21185021
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.
Glueck CJ; Budhani SB; Masineni SS; Abuchaibe C; Khan N; Wang P; Goldenberg N
Curr Med Res Opin; 2011 Sep; 27(9):1683-90. PubMed ID: 21728907
[TBL] [Abstract][Full Text] [Related]
9. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
Taylor BA; Lorson L; White CM; Thompson PD
Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
[TBL] [Abstract][Full Text] [Related]
10. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
11. Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment.
Kang JH; Nguyen QN; Mutka J; Le QA
J Pharm Pract; 2017 Oct; 30(5):521-527. PubMed ID: 27798247
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 160 cases of statin-induced myopathy].
Jiang Y; Lou Y; Liu Y; Wang L; Pang H; Zhang J; Zhou Y; Li Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):905-9. PubMed ID: 25620251
[TBL] [Abstract][Full Text] [Related]
13. The tolerability and efficacy of low-dose simvastatin in statin-intolerant patients.
Degreef LE; Opdam FL; Teepe-Twiss IM; Jukema JW; Guchelaar HJ; Tamsma JT
Eur J Intern Med; 2010 Aug; 21(4):293-6. PubMed ID: 20603038
[TBL] [Abstract][Full Text] [Related]
14. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
Forcadell-Peris MJ; de Diego-Cabanes C
Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
[TBL] [Abstract][Full Text] [Related]
15. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
16. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.
Calza L; Magistrelli E; Colangeli V; Borderi M; Contadini I; Bon I; Re MC; Viale P
AIDS; 2017 Mar; 31(5):681-688. PubMed ID: 28060020
[TBL] [Abstract][Full Text] [Related]
17. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.
Taylor BA; Lorson L; White CM; Thompson PD
Atherosclerosis; 2015 Feb; 238(2):329-35. PubMed ID: 25545331
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
20. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
Harper CR; Jacobson TA
Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
